Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers

被引:46
作者
Bensaidane, Mohamed Reda [1 ]
Beauregard, Jean-Mathieu [2 ]
Poulin, Stephane [1 ]
Buteau, Francois-Alexandre [2 ]
Guimond, Jean [2 ]
Bergeron, David [1 ]
Verret, Louis [1 ,3 ]
Fortin, Marie-Pierre [1 ]
Houde, Michele [1 ]
Bouchard, Remi W. [1 ,3 ]
Soucy, Jean-Paul [4 ]
Laforce, Robert Jr [1 ,3 ]
机构
[1] CHU Quebec, Clin Interdisciplinaire Memoire CIME, 1401 18ieme Rue, Quebec City, PQ G1J 1Z4, Canada
[2] CHU Quebec, Dept Imagerie Med, Quebec City, PQ G1J 1Z4, Canada
[3] Univ Laval, Dept Neurol Sci, Quebec City, PQ G1K 7P4, Canada
[4] McGill Univ, Montreal, PQ H3A 2T5, Canada
关键词
Alzheimer's disease; Alzheimer variants; amyloid PET imaging; atypical dementia; caregivers; differential diagnosis; frontotemporal lobar degeneration; impact; primary progressive aphasia; clinical utility; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; APPROPRIATE USE CRITERIA; NEURITIC PLAQUE DENSITY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; NATIONAL INSTITUTE; DECISION-MAKING; BETA PLAQUES; FDG-PET;
D O I
10.3233/JAD-151180
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have supported a role for amyloid positron emission tomography (PET) imaging in distinguishing Alzheimer's disease (AD) pathology from other pathological protein accumulations leading to dementia. We investigated the clinical utility of amyloid PET in the differential diagnosis of atypical dementia cases and its impact on caregivers. Using the amyloid tracer 18F-NAV4694, we prospectively scanned 28 patients (mean age 59.3 y, s.d. 5.8; mean MMSE 21.4, s.d. 6.0) with an atypical dementia syndrome. Following a comprehensive diagnostic workup (i.e., history taking, neurological examination, blood tests, neuropsychological evaluation, MRI, and FDG-PET), no certain diagnosis could be arrived at. Amyloid PET was then conducted and classified as positive or negative. Attending physicians were asked to evaluate whether this result led to a change in diagnosis or altered management. They also reported their degree of confidence in the diagnosis. Caregivers were met after disclosure of amyloid PET results and completed a questionnaire/interview to assess the impact of the scan. Our cohort was evenly divided between positive (14/28) and negative (14/28) 18F-NAV4694 cases. Amyloid PET resulted in a diagnostic change in 9/28 cases (32.1%: 17.8% changed from AD to non-AD, 14.3% from non-AD to AD). There was a 44% increase in diagnostic confidence. Altered management occurred in 71.4% (20/28) of cases. Knowledge of amyloid status improved caregivers' outcomes in all domains (anxiety, depression, disease perception, future anticipation, and quality of life). This study suggests a useful additive role for amyloid PET in atypical cases with an unclear diagnosis beyond the extensive workup of a tertiary memory clinic. Amyloid PET increased diagnostic confidence and led to clinically significant alterations in management. The information gained from that test was well received by caregivers and encouraged spending quality time with their loved ones.
引用
收藏
页码:1251 / 1262
页数:12
相关论文
共 38 条
[1]   Donepezil-Induced Confusional State in a Patient With Autopsy-Proven Behavioral-Variant Frontotemporal Dementia [J].
Arciniegas, David B. ;
Anderson, C. Alan .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (03) :E25-E26
[2]   Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study [J].
Barthel, Henryk ;
Gertz, Hermann-Josef ;
Dresel, Stefan ;
Peters, Oliver ;
Bartenstein, Peter ;
Buerger, Katharina ;
Hiemeyer, Florian ;
Wittemer-Rump, Sabine M. ;
Seibyl, John ;
Reininger, Cornelia ;
Sabri, Osama .
LANCET NEUROLOGY, 2011, 10 (05) :424-435
[3]   Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010 [J].
Beach, Thomas G. ;
Monsell, Sarah E. ;
Phillips, Leslie E. ;
Kukull, Walter .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (04) :266-273
[4]  
Bensaidane M, 2014, J NEUROL DISORD, V2, P2
[5]   Untangling Alzheimer's Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability - An Effort to Understand a Complex Disease [J].
Bergeron, David ;
Bensaidane, Reda ;
Laforce, Robert, Jr. .
CURRENT ALZHEIMER RESEARCH, 2016, 13 (05) :589-596
[6]   Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease [J].
Blennow, Kaj ;
Dubois, Bruno ;
Fagan, Anne M. ;
Lewczuk, Piotr ;
de Leon, Mony J. ;
Hampel, Harald .
ALZHEIMERS & DEMENTIA, 2015, 11 (01) :58-69
[7]   Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial [J].
Boxer, Adam L. ;
Knopman, David S. ;
Kaufer, Daniel I. ;
Grossman, Murray ;
Onyike, Chiadi ;
Graf-Radford, Neill ;
Mendez, Mario ;
Kerwin, Diana ;
Lerner, Alan ;
Wu, Chuang-Kuo ;
Koestler, Maly ;
Shapira, Jill ;
Sullivan, Kathryn ;
Klepac, Kristen ;
Lipowski, Kristine ;
Ullah, Jerin ;
Fields, Scott ;
Kramer, Joel H. ;
Merrilees, Jennifer ;
Neuhaus, John ;
Mesulam, M. Marsel ;
Miller, Bruce L. .
LANCET NEUROLOGY, 2013, 12 (02) :149-156
[8]  
Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4
[9]   Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand [J].
Cselenyi, Zsolt ;
Jonhagen, Maria Eriksdotter ;
Forsberg, Anton ;
Halldin, Christer ;
Julin, Per ;
Schou, Magnus ;
Johnstrom, Peter ;
Varnas, Katarina ;
Svensson, Samuel ;
Farde, Lars .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (03) :415-424
[10]   Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density [J].
Curtis, Craig ;
Gamez, Jose E. ;
Singh, Upinder ;
Sadowsky, Carl H. ;
Villena, Teresa ;
Sabbagh, Marwan N. ;
Beach, Thomas G. ;
Duara, Ranjan ;
Fleisher, Adam S. ;
Frey, Kirk A. ;
Walker, Zuzana ;
Hunjan, Arvinder ;
Holmes, Clive ;
Escovar, Yavir M. ;
Vera, Carla X. ;
Agronin, Marc E. ;
Ross, Joel ;
Bozoki, Andrea ;
Akinola, Mary ;
Shi, Jiong ;
Vandenberghe, Rik ;
Lkonomovic, Milos D. ;
Sherwin, Paul F. ;
Grachev, Igor D. ;
Farrar, Gillian ;
Smith, Adrian P. L. ;
Buckley, Christopher J. ;
McLain, Richard ;
Salloway, Stephen .
JAMA NEUROLOGY, 2015, 72 (03) :287-294